Monetizing Science: Turning an Asset into Value through IPOs
PharmaTalkRadio16 Okt 2019

Monetizing Science: Turning an Asset into Value through IPOs

This panel moderated by Dr Andrew Baum, Citi and recorded at the 5th annual IO360° Summit discusses the preparation of an IPO, straight licensing with the transition to a public company and decision making on prioritization within portfolios. Panelists include: David Epstein, Flagship PioneeringDan Passeri, Cue Biopharma Save the date for the 6th annual Immuno-Oncology 360° Summit on February 26-28, 2020 at the Crowne Plaza Times Square in New York City. Learn more at www.io360summit.com

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(461)

Populärt inom Vetenskap

p3-dystopia
dumma-manniskor
allt-du-velat-veta
kapitalet-en-podd-om-ekonomi
medicinvetarna
rss-ufobortom-rimligt-tvivel
svd-nyhetsartiklar
rss-spraket
det-morka-psyket
rss-vetenskapsradion
sexet
halsorevolutionen
paranormalt-med-caroline-giertz
dumforklarat
rss-vetenskapsradion-2
rss-arkeologi-historia-podden-som-graver-i-vart-kulturlandskap
vetenskapsradion
rss-ronden
4health-med-anna-sparre
rss-italiensk-dagbok